These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10830678)

  • 1. Lack of t-PA use for acute ischemic stroke in a community hospital: high incidence of exclusion criteria.
    Engelstein E; Margulies J; Jeret JS
    Am J Emerg Med; 2000 May; 18(3):257-60. PubMed ID: 10830678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
    Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
    Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes.
    Scott PA; Silbergleit R
    Ann Emerg Med; 2003 Nov; 42(5):611-8. PubMed ID: 14581912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of emergency medical service increases chance of thrombolytic therapy in patients with acute ischemic stroke.
    Hsieh MJ; Tang SC; Chiang WC; Huang KY; Chang AM; Ko PC; Tsai LK; Jeng JS; Ma MH
    J Formos Med Assoc; 2014 Nov; 113(11):813-9. PubMed ID: 24296308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke.
    Kunisawa S; Kobayashi D; Lee J; Otsubo T; Ikai H; Yokota C; Minematsu K; Imanaka Y
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):724-31. PubMed ID: 23910512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.
    Demaerschalk BM; Kleindorfer DO; Adeoye OM; Demchuk AM; Fugate JE; Grotta JC; Khalessi AA; Levy EI; Palesch YY; Prabhakaran S; Saposnik G; Saver JL; Smith EE;
    Stroke; 2016 Feb; 47(2):581-641. PubMed ID: 26696642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the Benefit of Prehospital Rapid Treatment in Acute Stroke: Benchmark for Future Innovative Clinical Trials.
    Lorenz MW; Lauer A; Foerch C
    Stroke; 2015 Nov; 46(11):3168-76. PubMed ID: 26443833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion.
    Asaithambi G; Chaudhry SA; Hassan AE; Rodriguez GJ; Suri MF; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e42-5. PubMed ID: 22572162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis.
    Smith RW; Scott PA; Grant RJ; Chudnofsky CR; Frederiksen SM
    Acad Emerg Med; 1999 Jun; 6(6):618-25. PubMed ID: 10386679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prehospital triage to primary stroke centers and rate of stroke thrombolysis.
    Prabhakaran S; O'Neill K; Stein-Spencer L; Walter J; Alberts MJ
    JAMA Neurol; 2013 Sep; 70(9):1126-32. PubMed ID: 23817961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
    Barber PA; Zhang J; Demchuk AM; Hill MD; Buchan AM
    Neurology; 2001 Apr; 56(8):1015-20. PubMed ID: 11320171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
    Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
    Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis candidates for the treatment of stroke at an emergency department in Japan.
    Yamaguchi K; Hori S; Nogawa S; Tanahashi N; Fukuuchi Y; Aikawa N
    Acad Emerg Med; 2002 Jul; 9(7):754-8. PubMed ID: 12093719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
    Stroke; 1997 Aug; 28(8):1530-40. PubMed ID: 9259745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
    George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
    MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.
    Mione G; Ducrocq X; Thilly N; Lacour JC; Vespignani H; Richard S
    Geriatr Gerontol Int; 2016 Jul; 16(7):843-9. PubMed ID: 26245693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.